Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)
1 clinical trials · Condition
◉ Watch Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies (NCT02740985) | AstraZeneca | 2016-06-17 |
Track Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC) automatically
Every clearance here is in the API, with alerts when new ones post.